Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Liquidia Corp (NQ: LQDA )

6.385 -0.025 (-0.39%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 280,846
Open 6.450
Bid (Size) 6.360 (4)
Ask (Size) 6.630 (9)
Prev. Close 6.410
Today's Range 6.320 - 6.500
52wk Range 4.350 - 9.950
Shares Outstanding 64,741,096
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
United Therapeutics Corporation Files Lawsuit Alleging Infringement of Tyvaso Patent Already Found to Be Invalid by U.S. Patent Office
From Liquidia Corporation
Via GlobeNewswire
United Therapeutics: A Strong Quarter But What About 2024?
United Therapeutics had strong Tyvaso sales but it highlights the investor debate heading into 2024. 
Via Talk Markets

Performance

YTD
+4.84%
+4.84%
1 Month
-9.82%
-9.82%
3 Month
-28.98%
-28.98%
6 Month
-7.06%
-7.06%
1 Year
+20.02%
+20.02%

More News

Read More
What 5 Analyst Ratings Have To Say About Liquidia
Via Benzinga
Liquidia Corporation Reports Second Quarter 2023 Financial Results and Provides Corporate Update
From Liquidia Corporation
Via GlobeNewswire
Preview: Liquidia's Earnings
Via Benzinga
Where Liquidia Stands With Analysts
Via Benzinga
Where Liquidia Stands With Analysts
Via Benzinga
Liquidia: Q1 Earnings Insights
Via Benzinga
Why Maxeon Solar Technologies Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal
Liquidia Corporation to Report Second Quarter 2023 Financial Results on August 10, 2023
From Liquidia Corporation
Via GlobeNewswire
Earnings Outlook For Liquidia
Via Benzinga
Earnings Scheduled For August 10, 2023
Via Benzinga
Liquidia Submits Amendment to Add PH-ILD Indication to Tentatively Approved NDA for YUTREPIA™ (treprostinil) Inhalation Powder
From Liquidia Corporation
Via GlobeNewswire
Why Ryanair Holdings Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
U.S. Federal Circuit Affirms All District Court Rulings in Patent Litigation
From Liquidia Corporation
Via GlobeNewswire
Why Franklin Covey Shares Are Trading Higher By 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
BioXcel Therapeutics, Alvotech And Other Big Stocks Moving Lower On Thursday
Via Benzinga
Liquidia Corporation and Pharmosa Biopharm Announce Collaboration for Sustained-Release Inhaled Treprostinil Product in North America
From Liquidia Corporation
Via GlobeNewswire
Liquidia Corporation to Present at the 2023 Jefferies Healthcare Conference
From Liquidia Corporation
Via GlobeNewswire
Hero or Zero? 7 High-Risk Stocks to Make You Rich… Or Broke.
Via InvestorPlace
Liquidia Announces Poster Presentation at the 2023 American Thoracic Society International Conference
From Liquidia Corporation
Via GlobeNewswire
Liquidia Corporation Reports First Quarter 2023 Financial Results and Provides Corporate Update
From Liquidia Corporation
Via GlobeNewswire
Liquidia Corporation to Present at BofA Securities 2023 Health Care Conference
From Liquidia Corporation
Via GlobeNewswire
Liquidia Corporation to Report First Quarter 2023 Financial Results on May 4, 2023
From Liquidia Corporation
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.